Zoe D. Draelos, MD, from Duke University, notes that clascoterone cream's unique sebum reduction mechanism provides effective, highly tolerable, and core acne treatment. The first episode of the ...
Ascletis Pharma has reported positive topline Phase III results showing that denifanstat (ASC40), a first-in-class oral FASN inhibitor for moderate-to-severe acne, delivered a favorable long-term ...
Sebum is the number one enemy of human skin. That’s what dermatologist Dr. Rachael Eckel of The Skin Health Institute in Trinidad and Medical Advisor for ZO Skin Health believes, since excess sebum is ...
Please provide your email address to receive an email when new articles are posted on . Infants with atopic dermatitis at age 1 month had higher expression of genes involved in immune responses. Sebum ...
Struggling with acne and pigmentation? Discover expert-recommended tips, skincare habits, and treatments to reduce dark spots ...
Vietnam Investment Review on MSN
Ascletis Acne Drug Shows Positive Phase Three Results
HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced positive topline results from the Phase III open-label study (NCT06248008) evaluating denifanstat ...
Unlike teenage breakouts, which are mainly driven by hormonal fluctuation, the causes of adult acne are more complex and “still not as well understood”, added Dr Sarah Too, medical director of Astria ...
Learn more about what causes acne in humans and how it can sometimes impact animals, too.
Stubborn acne represents one of skincare’s most frustrating challenges. Despite following standard cleansing routines and using popular over-the-counter products, many people continue experiencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results